DSG2 and cardiomyopathy: We recently reported a case of desmoglein-2-deficient cardiomyopathy caused by a rare homozygous stop-gain mutation and established isogenic iPSC-CMs from the patient lacking desmoglein-2 (Shiba et al., 2021).